Suchard, Semaglutide and Neovascular Age-Related Macular Degeneration Among Adults with Type 2 Diabetes: An OHDSI Network Study, Ophthalmology, Dr Kamal Kant Kohli-MBBS, DTCD- a chest specialist with more than 30 years of practice and a flair for writing clinical articles, Dr Kamal Kant Kohli joined Medical Dialogues as a Chief Editor of Medical News
Customer Support Knowledgeable team ready to assist with your research needs
Oral semaglutide reduced major adverse cardiovascular events by 14% compared to placebo (hazard ratio 0.86, 95% CI 0.77-0.96)
While hiccups are generally benign and self-limiting, persistent episodes lasting more than 48 hours warrant medical evaluation to rule out other causes
Retatrutide: A Triple Threat in Metabolic Regulation Retatrutide stands as a cutting-edge pharmaceutical peptide, developed by Eli Lilly, designed to address the complex challenges of obesity and type 2 diabetes